Most people assume that if a chemical passes standard toxicity screening, its biological risks are well characterized. That assumption is now seriously undermined. A methodological breakthrough covering a vastly larger slice of human biology than existing platforms suggests thousands of environmental chemicals — including the notorious 'forever chemicals' — may be disrupting proteins never previously implicated in their toxicity.
The research, published in PNAS, centers on a newly developed high-throughput protein affinity mapping platform capable of probing human protein targets well beyond the roughly 1.5% of the proteome currently assessed by mainstream in vitro toxicology tools like the EPA's ToxCast database. Applied to PFAS (per- and polyfluoroalkyl substances) and a broad set of ToxCast compounds, the system identified previously unmapped protein binding interactions, revealing bioactivity signatures that conventional assays would never detect. The platform's design allows simultaneous screening across a dramatically expanded set of protein targets, effectively compressing what once required years of individual assays into a scalable, high-throughput workflow.
The practical weight of this finding extends well beyond academic toxicology. PFAS compounds are detected in the blood of virtually every adult in industrialized nations and are linked epidemiologically to endocrine disruption, immune suppression, liver disease, and elevated cancer risk — yet the precise molecular mechanisms have remained elusive. Expanding proteome coverage from 1.5% to a substantially higher fraction is not an incremental refinement; it is closer to a paradigm shift in how chemical hazard is assessed. A critical limitation to acknowledge is that binding affinity does not automatically equal functional disruption — a chemical can interact with a protein without meaningfully altering its activity. Translating these newly discovered interactions into confirmed toxicological pathways will require substantial follow-up experimental and epidemiological work. Still, this platform represents a genuine inflection point, offering regulators and researchers a far more complete molecular portrait of chemical toxicity than was previously achievable.